TickerFiles

AVAI BIO, INC. 10-K filing

Filed 2026-07-14 · Report date 2026-03-31 · 2026 FY

View Original SEC Filing

Filing metadata

Accession number
0001740797-26-000017
Form type
10-K
CIK
0001740797
Primary document
https://www.sec.gov/Archives/edgar/data/1740797/000174079726000017/avai_10k2026.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for AVAI BIO, INC..

Reported financial metrics

MetricCurrentPriorChange
Operating Income$-1.7M--
Net Income$-1.7M--
Eps Basic-0.01--
Cash And Equivalents$23,145--
Total Assets$572,696--
Total Liabilities$3.4M--
Shareholders Equity$-2.8M--
Operating Cash Flow$-1.0M--